Skip to main content
ADBIOTECH Co.,Ltd. logo

ADBIOTECH Co.,Ltd. — Investor Relations & Filings

Ticker · 179530 ISIN · KR7179530001 KO Manufacturing
Open in API
Filings indexed 414 across all filing types
Latest filing 2025-09-29 Major Shareholding Noti…
Country KR South Korea
Listing KO 179530

About ADBIOTECH Co.,Ltd.

http://www.adbiotech.com

ADBIOTECH Co., Ltd. is a biotechnology company specializing in the development and commercialization of immune antibodies. The company's core competency is IgY (Immunoglobulin in Yolk) technology, which utilizes antibodies derived from eggs to create alternatives to conventional vaccines and antibiotics. Its product portfolio targets the livestock, aquaculture, and human health sectors, with applications for disease prevention and treatment in animals like salmon and shrimp, as well as human-focused developments for conditions related to Helicobacter pylori and cholesterol. The company manages the entire value chain from research and development to production and sales. ADBIOTECH is also expanding its technological capabilities into VHH (nanobody) technology, with a strategic focus on the global companion animal market.

Recent filings

Filing Released Lang Actions
[기재정정]주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is titled '주식등의 대량보유상황보고서' which translates to 'Report on Large Shareholding Status'. It details changes in large shareholdings, including specific share transactions, dates, and reasons such as stock transfer contracts and executive retirements. The document includes detailed tables of shareholdings before and after changes, identities of shareholders, and explanations of the changes. There is no indication that this is an announcement of a report publication or a certification. The content is a detailed report on major shareholding notifications, consistent with filings that disclose significant changes in share ownership levels. Therefore, the document fits the category of Major Shareholding Notification (MRQ).
2025-09-29 Korean
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' which translates to 'Report on Ownership of Specific Securities by Executives and Major Shareholders.' It details changes in share ownership, including dates, share counts, and transaction reasons such as completion of stock transfer contracts. The document includes personal information of the reporting individual, shareholding percentages, and detailed transaction history. This matches the description of a Major Shareholding Notification, which reports changes in significant share ownership levels. The document is about a specific ownership change and not about financial results, management changes, or other report types. The length is about 3350 characters, which is typical for such notifications. Therefore, the correct classification is Major Shareholding Notification (MRQ).
2025-09-29 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 85% confidence The document is a Korean regulatory “주요사항보고서(유상증자결정)” (Major Event Report – decision to increase capital by issuing new shares). It contains detailed terms and schedules for a paid-in capital increase and even a correction to the original filing. This is not an earnings release, management change, or annual/interim report, but a direct announcement of new share issuance (capital change). According to our taxonomy, this maps to Share Issue/Capital Change (Code: SHA).
2025-09-26 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 95% confidence The document is a Korean “주식등의 대량보유상황보고서(약식)” – a mandatory large shareholding report detailing number of shares, ratios, changes and acquisition methods for a significant shareholder crossing the 5% threshold. It is not an AGM material, earnings release, or management announcement but clearly a Major Shareholding Notification under the capital markets rules.
2025-09-26 Korean
[기재정정]주주총회소집결의 (임시주주총회)
AGM Information Classification · 98% confidence The document is a formal 'Correction Report' (정정신고) regarding a 'Notice of Convocation of Extraordinary General Meeting of Shareholders' (주주총회소집결의). It details changes to the agenda items (specifically the appointment of directors) for an upcoming meeting. This type of document is a standard proxy-related filing used to inform shareholders of meeting details and agenda changes, which falls under the Proxy Solicitation & Information Statement category.
2025-09-15 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of Extraordinary General Meeting' (임시주주총회 소집공고) issued by Adbiotech. It includes the meeting agenda, date, location, and detailed information regarding director appointments and governance matters. This type of document is classified as a Proxy Solicitation & Information Statement (PSI) because it provides shareholders with the necessary information to vote on specific agenda items at an upcoming meeting.
2025-09-15 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.